Masatoshi Saito

Prof. Dr. Masatoshi Saito


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 July 2021 in Abdominal Radiology
Verified
Journal Article
Closed access
PDF file
HRHainan Ren
Hainan Ren
NMNaoko Mori
Naoko Mori
SMShunji Mugikura
Shunji Mugikura
HSHiroaki Shimizu
Hiroaki Shimizu
SKSakiko Kageyama
Sakiko Kageyama
KTKei TAKASE
Kei TAKASE

Verified
Journal Article
Open access
PDF file
CGCharlotte van Gorp
Charlotte van Gorp
ILIlse de Lange
Ilse de Lange
KMKimberly R.I. Massy
Kimberly R.I. Massy
LKLilian Kessels
Lilian Kessels
AJAlan H Jobe
Alan H Jobe
Tim WolfsTim Wolfs
Tim Wolfs
Chorioamnionitis, an important cause of preterm birth, is linked to necrotizing enterocolitis (NEC). NEC is characterized by a disrupted mucus barrier, goblet cell loss, and endoplasmic reticulum (ER) stress of the intestinal epithelium. These findings prompted us to investigate the mechanisms underlying goblet cell alterations over time in an ovine chorioamnionitis model. Fetal lambs were intra-amniotically (IA) exposed to lipopolysaccharides (LPS) for 5, 12, or 24 h, or 2, 4, 8, or 15 d before premature delivery at 125 d gestational age (GA). Gut inflammation, the number, distribution, and differentiation of goblet cells, ER stress, and apoptosis were measured. We found a biphasic reduction in goblet cell numbers 24 h–2 d after, and 15 d after IA LPS exposure. The second decrease of goblet cell numbers was preceded by intestinal inflammation, apoptosis, and crypt ER stress, and increased SAM-pointed domain-containing ETS transcription factor (SPDEF)-positive cell counts. Our combined findings indicated that ER stress drives apoptosis of maturating goblet cells during chorioamnionitis, ultimately reducing goblet cell numbers. As similar changes have been described in patients suffering from NEC, these findings are considered to be clinically important for understanding the predecessors of NEC, and targeting ER stress in this context is interesting for future therapeutics.

21 August 2019 in Current Obstetrics and Gynecology Reports
Verified
Journal Article
Closed access
PDF file
YKYusaku Kumagai
Yusaku Kumagai
MKMatthew W. Kemp
Matthew W. Kemp
NYNobuo Yaegashi
Nobuo Yaegashi
MSMasatoshi Saito
Masatoshi Saito

21 July 2025 in European Journal of Obstetrics & Gynecology and Reproductive Biology
Verified
Journal Article
Closed access
MOManabu Ogoyama
Manabu Ogoyama
Junichi HasegawaJunichi Hasegawa
Junichi Hasegawa
KKKohei Kitada
Kohei Kitada
AKAkitaka Kuramoto
Akitaka Kuramoto
KOKohei Ogawa
Kohei Ogawa
HTHironori Takahashi
Hironori Takahashi

18 April 2023 in Reproductive Medicine
Verified
Journal Article
Open access
PDF file
MIMami Ishikuro
Mami Ishikuro
TOTaku Obara
Taku Obara
KMKeiko Murakami
Keiko Murakami
FUFumihiko Ueno
Fumihiko Ueno
ANAoi Noda
Aoi Noda
SKShinichi Kuriyama
Shinichi Kuriyama
Infertility treatment is a possible factor in hypertensive disorders of pregnancy (HDP). Identifying the characteristics of pregnant women who have undergone infertility treatment and have a potential risk for HDP is valuable for its prevention and treatment. Using data from 12,456 pregnant Japanese women from the Tohoku Medical Megabank Project Birth and Three-Generation Cohort Study, the association between infertility treatment and HDP was analyzed. A multiple logistic regression model showed an association between infertility treatment and HDP (odds ratio, 1.34; 95% confidence interval, 1.05–1.72). In vitro fertilization/intracytoplasmic sperm injection were also associated with HDP. Moreover, these associations were observed even among women who were not overweight and did not smoke. The application of infertility treatment should be carefully considered, even among women with low modifiable risk factors.

14 February 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
HHHirotaka Hamada
Hirotaka Hamada
NINoriyuki Iwama
Noriyuki Iwama
HTHasumi Tomita
Hasumi Tomita
KTKazuma Tagami
Kazuma Tagami
NKNatsumi Kumagai
Natsumi Kumagai
TGThe Japan Environment and Children’s Study Group
The Japan Environment and Children’s Study Group
Congenital malformations are functional and structural alterations in embryonic or foetal development resulting from a variety of factors including maternal health status. This study aimed to investigate the association between maternal birth weight (MBW) and the prevalence of congenital malformations in offspring using data from a nationwide birth cohort study in Japan including 103,060 pregnancies. A binary logistic regression model with adjustment for various covariates revealed that an MBW of <2500 g (low MBW) was associated with an increased risk of congenital heart disease (adjusted odds ratio: 1.388, [95% confidence interval: 1.075–1.792]), angioma (1.491 [1.079–2.059]), and inguinal hernia (1.746, [1.189–2.565]), while those with an MBW of ≥4000 g (high MBW) were associated with congenital anomalies of the urinary tract (2.194, [1.261–3.819]) and arrhythmia (1.775, [1.157–2.725]) compared with those with an MBW of 3000–3499 g. Low MBW was associated with cleft lip and/or palate (1.473, [1.052–2.064]), congenital heart disease (1.615, [1.119–2.332]), genital organs (1.648, [1.130–2.405]), hypospadias (1.804, [1.130–2.881]), and inguinal hernia (1.484, [1.189–1.851]) in male infants and CAKUT (1.619, [1.154–2.273]) in female infants, whereas high MBW was associated with congenital heart disease (1.745, [1.058–2.877]) and CAKUT (2.470, [1.350–4.517]) in male infants. The present study is the first to demonstrate a link between MBW and congenital malformations in Japanese children. While these results must be interpreted with caution, MBW should be considered a major predictor of congenital malformation risk.